Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
Rev. Soc. Bras. Med. Trop
;
53: e20180498, 2020. tab
Article
in English
| LILACS
| ID: biblio-1057281
ABSTRACT
Abstract INTRODUCTION:
Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance.METHODS:
Data were obtained from ICUs between 2010 and 2013.RESULTS:
P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B.CONCLUSIONS:
Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Pseudomonas aeruginosa
/
Pseudomonas Infections
/
Cross Infection
Type of study:
Prevalence study
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2020
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal de São Paulo/BR
/
Universidade Presbiteriana Mackenzie/BR
Similar
MEDLINE
...
LILACS
LIS